Mark Orlando
Neurology · Weston, FLNPI 1699345850
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations.
Across 100 payments — averaging $32.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$572
- UCB, Inc.$413
- AstraZeneca$354
- Argenx US, Inc.$330
- Eisai Inc.$190
- EMD Serono, Inc.$173
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,269100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $572 |
| UCB, Inc. | 12 | $413 |
| AstraZeneca | 12 | $354 |
| Argenx US, Inc. | 5 | $330 |
| Eisai Inc. | 5 | $190 |
| EMD Serono, Inc. | 4 | $173 |
| Merz Pharmaceuticals, LLC | 4 | $164 |
| Genentech USA, Inc. | 2 | $161 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $142 |
| Novartis | 5 | $97 |
| Neurelis, Inc. | 4 | $85 |
| Medtronic | 2 | $79 |
| GSK | 1 | $70 |
| Amgen | 1 | $69 |
| TG Therapeutics, Inc. | 2 | $54 |
| Neurocrine Biosciences, Inc. | 3 | $48 |
| Novo Nordisk | 2 | $45 |
| Sunovion Pharmaceuticals Inc. | 2 | $42 |
| Acadia Pharmaceuticals Inc | 2 | $39 |
| Livanova USA, Inc. | 1 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Catalyst Pharmaceuticals, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| Boston Scientific | 1 | $21 |
| Acorda Therapeutics, Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$125
- VYVGART HYTRULO$125
- VYVGART$120
- XEOMIN$107
- Leqembi$107
How this compares
$3,269 in reported general payments places this provider in the 55th percentile of 1,434 neurology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 23 | $316 |
| Donepezil Hcl | 20 | $205 |
| Atorvastatin Calcium | 15 | $174 |
Paid to pharmacies, not to this prescriber.
Other neurology in Weston
- Paunel AgyeiWeston$206K
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
- Matthew BakerNaples$1.4M
- Donald NegroskiSarasota$1.4M
- Mark CascioneTampa$1.2M
- Lance KimOcala$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.